1. A randomized study investigating the effect of omeprazole on the pharmacokinetics of oral semaglutide. (3rd August 2018) Authors: Bækdal, Tine A.; Breitschaft, Astrid; Navarria, Andrea; Hansen, Cilie W. Journal: Expert opinion on drug metabolism and toxicology Issue: Volume 14:Number 8(2018) Page Start: 869 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial. Issue 5 (May 2020) Authors: Yamada, Yuichiro; Katagiri, Hideki; Hamamoto, Yoshiyuki; Deenadayalan, Srikanth; Navarria, Andrea; Nishijima, Keiji; Seino, Yutaka Journal: Lancet Issue: Volume 8:Issue 5(2020) Page Start: 377 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of upper gastrointestinal disease on the pharmacokinetics of oral semaglutide in subjects with type 2 diabetes. Issue 4 (17th January 2022) Authors: Meier, Juris J.; Granhall, Charlotte; Hoevelmann, Ulrike; Navarria, Andrea; Plum‐Moerschel, Leona; Ramesh, Chethana; Tannapfel, Andrea; Kapitza, Christoph Journal: Diabetes, obesity & metabolism Issue: Volume 24:Issue 4(2022) Page Start: 684 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial. Issue 5 (May 2020) Authors: Yabe, Daisuke; Nakamura, Jiro; Kaneto, Hideaki; Deenadayalan, Srikanth; Navarria, Andrea; Gislum, Mette; Inagaki, Nobuya Journal: Lancet Issue: Volume 8:Issue 5(2020) Page Start: 392 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial. Issue 4 (April 2018) Authors: Pratley, Richard E; Aroda, Vanita R; Lingvay, Ildiko; Lüdemann, Jörg; Andreassen, Camilla; Navarria, Andrea; Viljoen, Adie Journal: Lancet Issue: Volume 6:Issue 4(2018) Page Start: 275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice. (April 2016) Authors: Leggio, Gian Marco; Catania, Maria Vincenza; Puzzo, Daniela; Spatuzza, Michela; Pellitteri, Rosalia; Gulisano, Walter; Torrisi, Sebastiano Alfio; Giurdanella, Giovanni; Piazza, Cateno; Impellizzeri, Agata Rita; Gozzo, Lucia; Navarria, Andrea; Bucolo, Claudio; Nicoletti, Ferdinando; Palmeri, Agost... Journal: Pharmacological research Issue: Volume 106(2016:Apr.) Page Start: 10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice. (April 2016) Authors: Leggio, Gian Marco; Catania, Maria Vincenza; Puzzo, Daniela; Spatuzza, Michela; Pellitteri, Rosalia; Gulisano, Walter; Torrisi, Sebastiano Alfio; Giurdanella, Giovanni; Piazza, Cateno; Impellizzeri, Agata Rita; Gozzo, Lucia; Navarria, Andrea; Bucolo, Claudio; Nicoletti, Ferdinando; Palmeri, Agost... Journal: Pharmacological research Issue: Volume 106(2016:Apr.) Page Start: 10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗